Live Breaking News & Updates on Genitourinary Cancers|Page 2

Stay updated with breaking news from Genitourinary cancers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Dr Efstathiou on the Evolution of Trimodal Therapy in MIBC

Jason Efstathiou, MD, DPhil, discusses the utility of trimodal therapy in patients with muscle-invasive bladder cancer. ....

United States , Jason Efstathiou , Harvard Medical School , John Bertucci Center , National Comprehensive Cancer Network , Faculty Academic Affairs , Department Of Radiation Oncology , Genitourinary Service , Academic Affairs , Radiation Oncology , Genitourinary Cancers , Massachusetts General Hospital , Radiation Oncology Summit , Transurethral Resection , Bladder Tumor , Urothelial Cancer , Onclive Tv ,

Dr Garmezy on Factors Influencing Treatment Selection in Variant RCC

Benjamin Garmezy, MD, discusses key factors influencing treatment selection for patients with variant renal cell carcinoma.
....

United States , Benjamin Garmezy , Sarah Cannon Research Institute , Genitourinary Research , Tennessee Oncology , Genitourinary Cancers , Onclive Tv , Sarah Cannon Research Institute At Tennessee Oncology ,

Toripalimab Plus Axitinib Approved in China for Frontline Renal Cell Carcinoma

The NMPA of China has approved toripalimab plus axitinib for use in the first-line treatment of patients with medium- to high-risk unresectable or metastatic RCC. ....

Jun Guo , National Medical Products Administration Of China , Shanghai Junshi Biosciences Co Ltd , University Cancer Hospital , International Metastatic Renal Cell Carcinoma Database Consortium , National Medical Products Administration , Peking University Cancer Hospital , Global Oncology , Immuno Oncology , Genitourinary Cancers , Toripalimab Plus Axitinib , First Line Treatment Of Patients With Medium To High Risk Unresectable Or Metastatic Rcc , The National Medical Products Administration Of China ,

Dr Zhang on Topics of Ongoing Debate Within Prostate Cancer

Tian Zhang, MD, MHS, discusses areas of ongoing debate regarding prostate cancer management. ....

United States , Department Of Internal Medicine , University Of Texas Ut Southwestern Medical Center , Haroldc Simmons Comprehensive Cancer Center , Tian Zhang , Internal Medicine , Comprehensive Cancer Center , Southwestern Medical Center , United States Prostate Cancer Conference , Ut Southwestern Haroldc Simmons Comprehensive Cancer Center , Onclive Tv , Genitourinary Cancers ,

Trodelvy-Keytruda Combo Shows High Promise in Metastatic Bladder Cancer

A phase 2 trial showed that Trodelvy plus Keytruda had a high response rate with lasting responses, emphasizing “potential additive or synergistic effects,” an expert said. ....

Petros Grivas , National Cancer Institute , Fred Hutchinson Cancer Center , University Of Washington , National Cancer , Differentiating Muscle Invasive , Non Muscle Invasive Bladder , Getting Newly Approved Cancer Drugs May , Bladder Cancer , Genitourinary Cancers , Phase 2 Clinical Trials , Metastatic Bladder Cancer ,